Reverse SplitI see nothing indicating a reverse split. Currently there are 477.4M shares outstanding. The Company is attempting to work over these next three quarters with their current float of 17m to stay in budget operating on over 5m per quarter plus any other revenue streams. It's a wait and see kind of thing referring to any news releases coming soon, I'm sure. There are millions upon millions of people World wide with "refractory angina; quite the market potential the Reducer has with an aging population incidences are only going to get more common.